| 2024-05-13 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 8,151 0.0162% | $4.79 | $39,034 | -30.3% | |
| 2024-02-12 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 28,600 0.0574% | $4.62 | $132,143 | -17.19% | |
| 2024-01-04 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 721 0.0013% | $2.94 | $2,121 | +18.41% | |
| 2024-01-03 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 3,019 0.0061% | $3.12 | $9,416 | +24.83% | |
| 2023-12-11 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 33,839 0.0637% | $3.41 | $115,522 | +2.44% | |
| 2023-07-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 1,361 0.0026% | $2.45 | $3,339 | +2.21% | |
| 2023-01-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 729 0.0015% | $5.41 | $3,942 | -49.81% | |
| 2023-01-04 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 1,639 0.0032% | $5.58 | $9,138 | -52.75% | |
| 2022-09-13 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 18,000 0.042% | $15.71 | $282,746 | -79.9% | |
| 2022-07-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 648 0.0013% | $5.17 | $3,351 | +2.84% | |
| 2022-01-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 1,445 0.0036% | $10.61 | $15,334 | -16.8% | |
| 2021-04-22 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 15,000 0.0347% | $22.07 | $331,100 | -39.77% | |
| 2021-03-23 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 15,000 0.0374% | $21.94 | $329,060 | -31.73% | |
| 2021-03-02 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 15,000 0.0362% | $22.95 | $344,192 | -35.06% | |
| 2021-01-22 | Sale | G1 Therapeutics, Inc. GTHX | Chief Medical Officer | 15,000 0.0366% | $20.64 | $309,591 | -14.7% | |
| 2020-12-10 | Sale | G1 Therapeutics, Inc. GTHX | Ch. Medical Officer & SVP R&D | 18,000 0.0246% | $10.03 | $180,550 | +2.44% | |
| 2018-12-17 | Sale | G1 Therapeutics, Inc. GTHX | Ch. Medical Officer & SVP R&D | 7,552 0.0123% | $17.09 | $129,026 | -23.27% | |
| 2018-11-15 | Sale | G1 Therapeutics, Inc. GTHX | Ch. Medical Officer & SVP R&D | 7,552 0.0193% | $39.75 | $300,209 | -47.57% | |
| 2018-10-15 | Sale | G1 Therapeutics, Inc. GTHX | Ch. Medical Officer & SVP R&D | 7,552 0.0205% | $41.71 | $314,994 | -44.13% | |
| 2018-09-17 | Sale | G1 Therapeutics, Inc. GTHX | Ch. Medical Officer & SVP R&D | 7,552 0.0222% | $66.08 | $499,003 | -63.1% |